XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.81%15.41B | 2.33%3.96B | 4.28%3.9B | 2.31%3.81B | 2.33%3.74B | 3.98%14.98B | 3.45%3.87B | 4.88%3.74B | 5.28%3.73B | 2.35%3.65B |
Operating revenue | 2.81%15.41B | 2.33%3.96B | 4.28%3.9B | 2.31%3.81B | 2.33%3.74B | 3.98%14.98B | 3.45%3.87B | 4.88%3.74B | 5.28%3.73B | 2.35%3.65B |
Cost of revenue | 2.92%10.03B | 4.12%2.58B | 3.79%2.52B | 1.84%2.49B | 1.92%2.44B | 3.87%9.75B | 2.95%2.48B | 4.52%2.43B | 4.80%2.44B | 3.23%2.4B |
Gross profit | 2.60%5.38B | -0.86%1.38B | 5.19%1.38B | 3.19%1.33B | 3.11%1.29B | 4.20%5.24B | 4.35%1.39B | 5.56%1.31B | 6.20%1.29B | 0.72%1.25B |
Operating expense | -2.27%3.11B | -13.30%756M | 0.13%800M | 4.99%778M | 0.78%772M | -0.72%3.18B | -7.23%872M | 4.44%799M | -1.59%741M | 3.10%766M |
Selling and administrative expenses | -2.97%1.99B | -18.53%453M | 3.98%522M | 5.60%509M | -0.97%508M | -0.87%2.05B | -4.63%556M | -2.90%502M | -0.21%482M | 5.12%513M |
Depreciation amortization depletion | -0.98%1.11B | -4.11%303M | -6.40%278M | 3.86%269M | 4.35%264M | -0.44%1.13B | -11.48%316M | 19.76%297M | -4.07%259M | -0.78%253M |
-Depreciation and amortization | -0.98%1.11B | -4.11%303M | -6.40%278M | 3.86%269M | 4.35%264M | -0.44%1.13B | -11.48%316M | 19.76%297M | -4.07%259M | -0.78%253M |
Operating profit | 10.09%2.27B | 20.08%622M | 13.11%578M | 0.74%548M | 6.76%521M | 12.81%2.06B | 32.14%518M | 7.35%511M | 19.04%544M | -2.79%488M |
Net non-operating interest income expense | 2.04%-623M | 5.33%-160M | 5.99%-157M | 8.48%-151M | -14.81%-155M | -57.82%-636M | -38.52%-169M | -60.58%-167M | -79.35%-165M | -58.82%-135M |
Non-operating interest income | 30.56%47M | -8.33%11M | -7.14%13M | 200.00%12M | 83.33%11M | 176.92%36M | 100.00%12M | 250.00%14M | 100.00%4M | 500.00%6M |
Non-operating interest expense | -0.30%670M | -5.52%171M | -6.08%170M | -3.55%163M | 17.73%166M | 61.54%672M | 41.41%181M | 67.59%181M | 79.79%169M | 63.95%141M |
Other net income (expense) | -32.35%23M | 241.67%82M | -1,540.00%-72M | 1,075.00%39M | -388.89%-26M | 155.74%34M | 380.00%24M | 141.67%5M | 89.19%-4M | 152.94%9M |
Special income (charges) | 25.56%-67M | 117.39%4M | 6.67%-28M | -40.00%-28M | 11.76%-15M | -221.43%-90M | -76.92%-23M | -650.00%-30M | -400.00%-20M | -142.86%-17M |
-Less:Restructuring and merger&acquisition | -20.24%67M | -123.53%-4M | -6.67%28M | 40.00%28M | -11.76%15M | 200.00%84M | 30.77%17M | 650.00%30M | 400.00%20M | 142.86%17M |
-Less:Other special charges | ---- | ---- | ---- | ---- | ---- | --6M | ---- | ---- | ---- | ---- |
Other non- operating income (expenses) | -27.42%90M | 65.96%78M | -225.71%-44M | 318.75%67M | -142.31%-11M | 475.76%124M | 161.11%47M | 537.50%35M | 148.48%16M | 360.00%26M |
Income before tax | 14.39%1.67B | 45.84%544M | 0.00%349M | 16.27%436M | -6.08%340M | 7.04%1.46B | 35.64%373M | -3.06%349M | 14.33%375M | -9.50%362M |
Income tax | 198.02%301M | 209.80%112M | 27.45%65M | -7.41%75M | -30.99%49M | -61.15%101M | -312.50%-102M | -27.14%51M | 14.08%81M | 0.00%71M |
Earnings from equity interest net of tax | --5M | 183.33%5M | -80.00%1M | -33.33%2M | -50.00%-3M | --0 | ---6M | 171.43%5M | 400.00%3M | 50.00%-2M |
Net income | 1.10%1.37B | -6.82%437M | -5.94%285M | 22.22%363M | -0.35%288M | 24.47%1.36B | 106.61%469M | 7.07%303M | 16.02%297M | -11.08%289M |
Net income continuous Operations | 1.10%1.37B | -6.82%437M | -5.94%285M | 22.22%363M | -0.35%288M | 24.47%1.36B | 106.61%469M | 7.07%303M | 16.02%297M | -11.08%289M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 1.10%1.37B | -6.82%437M | -5.94%285M | 22.22%363M | -0.35%288M | 24.47%1.36B | 106.61%469M | 7.07%303M | 16.02%297M | -11.08%289M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 1.10%1.37B | -6.82%437M | -5.94%285M | 22.22%363M | -0.35%288M | 24.47%1.36B | 106.61%469M | 7.07%303M | 16.02%297M | -11.08%289M |
Basic earnings per share | 2.44%7.57 | -5.43%2.44 | -5.42%1.57 | 23.60%1.99 | 1.28%1.58 | 26.98%7.39 | 111.48%2.58 | 9.21%1.66 | 18.38%1.61 | -8.77%1.56 |
Diluted earnings per share | 2.74%7.49 | -4.72%2.42 | -4.91%1.55 | 23.90%1.97 | 1.96%1.56 | 27.45%7.29 | 111.67%2.54 | 9.40%1.63 | 18.66%1.59 | -8.93%1.53 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- | -- |